As of May 26
| -0.05 / -0.10%|
The 17 analysts offering 12-month price forecasts for Sanofi SA have a median target of 61.93, with a high estimate of 73.94 and a low estimate of 48.60. The median estimate represents a +17.88% increase from the last price of 52.54.
The current consensus among 21 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.